|
2025
|
G/S
|
Pharmaceutical preparations for immune-mediated inflammatory diseases; biologics for immune-media... |
|
|
G/S
|
Pharmaceutical preparations for immune-mediated inflammatory
diseases; biologics for immune-medi... |
|
2024
|
G/S
|
Pharmaceutical preparations for immune-mediated inflammatory diseases; Biologics for immune-media... |
|
|
G/S
|
Medical laboratory testing and research services; providing medical and scientific research infor... |
|
|
G/S
|
Medical laboratory testing and research services; providing
medical and scientific research info... |
|
2023
|
Invention
|
Pharmacokinetic modeling systems for improved therapeutic dosing. Provided herein are systems and... |
|
|
Invention
|
Indirect homogeneous mobility shift assays for the detection of biologics in patient samples.
Th... |
|
|
G/S
|
Medical research laboratory services featuring testing for medical research purposes; medical res... |
|
|
Invention
|
Methods for assessing mucosal healing in inflammatory bowel disease patients.
The present disclo... |
|
2022
|
Invention
|
Patient centric precision model for anti-tnf therapy.
Provided are systems and methods for treat... |
|
|
Invention
|
Patient centric precision model for anti-tnf therapy. Provided are systems and methods for treati... |
|
|
Invention
|
Methods for prediction of anti-tnf alpha drug levels and autoantibody formation.
In some aspects... |
|
|
Invention
|
Systems and methods for improved targeted therapy.
Provided herein are systems and methods for o... |
|
|
Invention
|
Systems and methods for improved targeted therapy. Provided herein are systems and methods for op... |
|
2021
|
Invention
|
Methods of disease activity profiling for personalized therapy management.
The present invention... |
|
|
Invention
|
Methods for assessing mucosal healing in ulcerative colitis disease patients. The present disclos... |
|
|
G/S
|
Medical testing services providing precision-guided dosing to help physicians achieve a set thera... |
|
|
G/S
|
Medical testing services assessing the likelihood of a medical patient achieving a set therapeuti... |
|
|
G/S
|
Medical laboratory services for testing and treating autoimmune diseases
Medical diagnostic testi... |
|
|
G/S
|
medical laboratory services for testing autoimmune diseases medical diagnostic testing for diagno... |
|
2020
|
G/S
|
Genetic testing for medical purposes |
|
2019
|
Invention
|
Methods for prediction of anti-tnf α drug levels and autoantibody formation. In some aspects, the... |
|
|
Invention
|
Indirect homogeneous mobility shift assays for the detection of biologics in patient samples. The... |
|
|
Invention
|
Assays for the detection of anti-tnf drugs and autoantibodies.
The present invention provides as... |
|
|
G/S
|
Medical laboratory services for gastrointestinal diseases and inflammatory bowel diseases; Medica... |
|
2018
|
Invention
|
Methods of disease activity profiling for personalized therapy management. The present invention ... |
|
|
Invention
|
Addressable antibody arrays and methods of use.
Systems and assay methods are disclosed for dete... |
|
|
Invention
|
Methods for assessing mucosal healing in crohn's disease patients. The present disclosure provide... |
|
|
Invention
|
Methods for assessing mucosal healing in crohn's disease patients. The present disclosure p... |
|
2017
|
Invention
|
Methods for establishing a vedolizumab dosing regimen to treat patients with irritable bowel dise... |
|
|
Invention
|
Methods for prediction of anti-tnfα drug levels and autoantibody formation. In some aspects, the ... |
|
|
G/S
|
Medical laboratory services in the fields of gastrointestinal diseases, namely, inflammatory bowe... |
|
|
G/S
|
Collection kits and reagents for collection and preservation of bodily fluids and feces for diagn... |
|
2016
|
Invention
|
Assays for the detection of anti-tnf drugs and autoantibodies. The present invention provides ass... |
|
|
Invention
|
Biomarker panel for assessment of mucosal healing. The present invention provides methods for pre... |
|
|
Invention
|
Methods for predicting post-operative recurrence of crohn's disease. The present invention provid... |
|
2015
|
Invention
|
Methods for predicting and monitoring mucosal healing.
The present invention provides methods fo... |
|
2014
|
Invention
|
Methods for improving inflammatory bowel disease diagnosis.
The present invention provides metho... |
|
2013
|
Invention
|
Methods for predicting and monitoring mucosal healing. The present invention provides methods for... |
|
|
Invention
|
Assays for detecting autoantibodies to anti-tnfalpha drugs.
The present invention provides assay... |
|
|
G/S
|
Medical laboratory services to determine and monitor markers of inflammatory bowel disease Medica... |
|
|
Invention
|
Methods for determining anti-drug antibody isotypes. The present invention provides assay methods... |
|
|
Invention
|
Methods for improving inflammatory bowel disease diagnosis. The present invention provides method... |
|
|
Invention
|
Methods for optimizing clinical responsiveness to methotrexate therapy using metabolite profiling... |
|
2012
|
Invention
|
Methods of predicting methotrexate efficacy and toxicity.
The present invention provides methods... |
|
|
Invention
|
Addressable antibody arrays and methods of use. Systems and assay methods are disclosed for detec... |
|
|
G/S
|
Medical laboratory services to determine and monitor levels of antibody drugs and anti-drug antib... |
|
2011
|
Invention
|
Her2delta16 peptides. The present invention provides cyclic peptides comprising a dimer of peptid... |
|
|
Invention
|
Inflammatory bowel disease prognostics.
The methods and systems of the present invention are use... |
|
|
Invention
|
Methods for determining anti-drug antibody isotypes. A method as disclosed herein includes ... |
|
|
Invention
|
Methods of quantifying methotrexate metabolites.
The present invention provides a method for eff... |
|
2010
|
Invention
|
Methods of diagnosing inflammatory bowel disease. The present invention provides methods, systems... |
|
|
Invention
|
Novel genomic biomarkers for irritable bowel syndrome diagnosis. The invention provides novel bio... |
|
|
Invention
|
Methods for predicting post-surgery risk associated with ileal pouch-anal anastomosis. The method... |
|
2007
|
G/S
|
Pharmaceutical preparations used for [ the treatment of gastrointestinal disorders and diseases, ... |
|
2004
|
G/S
|
Medical services, namely, medical diagnostic, testing and screening services; and related medical... |
|
2003
|
G/S
|
Medical services, namely, medical diagnostic, laboratory testing, evaluation and screening servic... |
|
2002
|
G/S
|
Pharmaceutical products, namely specimen kits comprised of containers, medical labels, medical pa... |
